Arthroscopic Versus Open Management of Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: A Meta-analysis of Retrospective Cohort Studies.

J Am Acad Orthop Surg Glob Res Rev

From the Rutgers Robert Wood Johnson Medical School, Piscataway, NJ (Mr. Chandra); Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA (Mr. Chandra and Dr. Abraham); Rothman Orthopaedic Institute, Philadelphia, PA (Mr. Chandra, Ms. Agarwal, Ms. Donahue and Dr. Abraham); Drexel University School of Medicine, Philadelphia, PA (Ms. Agarwal); Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA (Dr. Handorf) and the Sarcoma Center of Excellence, Capital Health Medical Center, Pennington, NJ (Dr. Abraham).

Published: December 2021

AI Article Synopsis

  • A study investigated whether arthroscopic or open surgery for diffuse-type tenosynovial giant cell tumor (D-TGCT) of the knee has different recurrence rates.
  • The analysis included data from 16 retrospective studies involving 1,143 patients and utilized random-effects meta-analyses to compare outcomes.
  • Results showed that arthroscopic procedures had a 1.56 times higher risk of recurrence than open procedures, while overall complications from both methods were low.

Article Abstract

Background: Whether arthroscopic or open surgical management for diffuse-type tenosynovial giant cell tumor (D-TGCT) of the knee is associated with a lower rate of recurrence is unknown.

Methods: PubMed, Scopus, Web of Science, Cochrane, and EMBASE were searched on December 3, 2020. Retrospective studies that reported on recurrence rates for arthroscopic versus open management of D-TGCT were included. A total of 16 studies evaluating 1143 patients with D-TGCT of the knee were included (nopen = 551, narthroscopic = 350 patients, and narthroscopic/open = 23 patients). Random-effects meta-analyses were used to summarize and compare the reported recurrence rates, stratified by approach and overall recurrence. The meta-analysis was registered with PROSPERO.

Results: The recurrence rate per year (incidence) for arthroscopic procedures was 0.11 (95% CI 0.08 to 0.16, P < 0.0001) and for open procedures was 0.07 (95% CI 0.04 to 0.13, P < 0.0001). There was a 1.56 times (95% CI 1.04 to 2.34, P = 0.0332) increased risk of recurrence when treating D-TGCT of the knee with an arthroscopic approach. When evaluating only the subset of studies that had data for both arthroscopic and open approaches, the incidence rate per year for arthroscopic procedures was 0.17 (95% CI 0.11 to 0.27, P < 0.0001) and for open procedures was 0.11 (95% CI 0.06 to 0.19, P < 0.0001). The rate of overall complications was 0.04 (95% CI 0.01 to 0.08, P < 0.0001).

Conclusion: Arthroscopic surgical management of D-TGCT of the knee in our study resulted in a 1.56 times risk of recurrence as compared with the open approach. The percent of overall complications was minimal.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667987PMC
http://dx.doi.org/10.5435/JAAOSGlobal-D-21-00217DOI Listing

Publication Analysis

Top Keywords

d-tgct knee
16
arthroscopic
8
arthroscopic versus
8
versus open
8
open management
8
management diffuse-type
8
diffuse-type tenosynovial
8
tenosynovial giant
8
giant cell
8
cell tumor
8

Similar Publications

Diffuse tenosynovial giant cell tumor (D-TGCT), previously known as pigmented villonodular synovitis (PVNS), is a benign, aggressive, and distracting proliferative synovial lesion. D-TGCT is commonly seen in large joints such as the knee and hip. We present the case of a 57-year-old female who initially presented with swelling on the left midfoot that increased over four years.

View Article and Find Full Text PDF

A Case Report of Diffuse-type Tenosynovial Giant Cell Tumor as a Calcaneus Mass: A Diagnostic Challenge.

Curr Med Imaging

March 2024

Department of Radiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R., China.

Introduction: Diffuse-type tenosynovial giant cell tumor (D-TGCT) originates from synovial cells in tendon sheaths and bursae and rarely presents as a calcaneal mass.

Case Report: A 44-year-old female presented with left heel pain that had persisted for over a year and had worsened over the past six months. A mass was found on the Lateral radiograph of the calcaneus, which was diagnosed as an aneurysmal bone cyst.

View Article and Find Full Text PDF

Background: Diffuse-type tenosynovial giant-cell tumor (D-TGCT), formerly known as pigmented villonodular synovitis, is a rare, locally aggressive, invasive soft tissue tumor that primarily occurs in the knee. Surgical excision is the main treatment option, but there is a high recurrence rate. Arthroscopic surgical techniques are emphasized because they are less traumatic and offer faster postoperative recovery, but detailed reports on arthroscopic techniques and outcomes of D-TGCT in large cohorts are still lacking.

View Article and Find Full Text PDF

Aims: Tenosynovial giant cell tumour (TGCT) is a rare benign tumour of the musculoskeletal system. Surgical management is fraught with challenges due to high recurrence rates. The aim of this study was to describe surgical treatment and evaluate surgical outcomes of TGCT at an Australian tertiary referral centre for musculoskeletal tumours and to identify factors affecting recurrence rates.

View Article and Find Full Text PDF

Objectives: Although the diffuse type of tenosynovial giant cell tumor (D-TGCT) is rare, bone involvement is common in such lesions. However, the optimal management of bone lesions in D-TGCT is not well-described. In this study, we reported the outcomes of total synovectomy, curettage, and bone grafting/cementation in the treatment of D-TGCT with subchondral bone involvement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!